The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design

FA Rey, K Stiasny, MC Vaney, M Dellarole… - EMBO reports, 2018 - embopress.org
Zika and dengue viruses belong to the Flavivirus genus, a close group of antigenically
related viruses that cause significant arthropod‐transmitted diseases throughout the globe …

Current development and challenges of tetravalent live-attenuated dengue vaccines

J Hou, W Ye, J Chen - Frontiers in Immunology, 2022 - frontiersin.org
Dengue is the most common arboviral disease caused by one of four distinct but closely
related dengue viruses (DENV) and places significant economic and public health burdens …

Magnitude of antibody cross-reactivity in medically important mosquito-borne flaviviruses: a systematic review

A Endale, G Medhin, K Darfiro, N Kebede… - Infection and drug …, 2021 - Taylor & Francis
Introduction Flaviviruses are a genus of enveloped single-stranded RNA viruses that include
dengue virus (DENV), yellow fever virus, West Nile virus (WNV), Japanese encephalitis …

Homotypic dengue virus reinfections in Nicaraguan children

JJ Waggoner, A Balmaseda, L Gresh… - The Journal of …, 2016 - academic.oup.com
Background. Infection with any of the 4 related dengue virus serotypes (DENV-1–4) is
thought to result in lifelong immunity to homotypic reinfection (ie, reinfection with the same …

The complexity of a dengue vaccine: a review of the human antibody response

J Flipse, JM Smit - PLoS neglected tropical diseases, 2015 - journals.plos.org
Dengue is the most prevalent mosquito-borne viral disease worldwide. Yet, there are no
vaccines or specific antivirals available to prevent or treat the disease. Several dengue …

[HTML][HTML] Safety and immunogenicity of a tetravalent dengue DNA vaccine administered with a cationic lipid-based adjuvant in a phase 1 clinical trial

JR Danko, T Kochel, N Teneza-Mora… - The American journal …, 2018 - ncbi.nlm.nih.gov
We conducted an open label, dose escalation Phase 1 clinical trial of a tetravalent dengue
DNA vaccine (TVDV) formulated in Vaxfectin® to assess safety and immunogenicity. A total …

Vertebrate reservoirs of arboviruses: Myth, synonym of amplifier, or reality?

G Kuno, JS Mackenzie, S Junglen, Z Hubálek… - Viruses, 2017 - mdpi.com
The rapid succession of the pandemic of arbovirus diseases, such as dengue, West Nile
fever, chikungunya, and Zika fever, has intensified research on these and other arbovirus …

Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies

D Buddhari, J Aldstadt, TP Endy… - PLoS neglected …, 2014 - journals.plos.org
Background Long-term homologous and temporary heterologous protection from dengue
virus (DENV) infection may be mediated by neutralizing antibodies. However, neutralizing …

[HTML][HTML] Serodiagnosis of asymptomatic dengue infection

S Chatchen, A Sabchareon, C Sirivichayakul - Asian Pacific journal of …, 2017 - Elsevier
Dengue virus (DENV) is a mosquito-transmitted virus that is expanding across the world.
The incidence of dengue infection, especially severe disease, has been increasing. DENV …

[HTML][HTML] Next generation dengue vaccines: a review of the preclinical development pipeline

KS Vannice, JT Roehrig, J Hombach - Vaccine, 2015 - Elsevier
Dengue represents a significant and growing public health problem across the globe, with
approximately half of the world's population at risk. The increasing and expanding burden of …